CS logo
small CS logo
Curie Manavata Cancer Centre

Maharashtra, India
Cancer treatment center in Nashik, Maharashtra
HCG Manavata Cancer Centre, near Mylan Circle, Mumbai Naka, Nashik, Maharashtra 422002

About Curie Manavata Cancer Centre


"One of the leading Cancer hospitals in India with a 275-bed capacity. Successfully treated more than 70000 patients since our inception in 2007 and adding on.Successfully treated 13000+ patients by Radiotherapy, 40000+ surgeries. More than 450 patients are showing their trust in the hospital daily.1st NABH Accredited cancer centre in Central India.1st Hospital in the region to launch an ultra modern dedicated Department of Nuclear Medicine with PET-CT Scan & Gamma Camera.1st Hospital in the region to launch the latest advancement in Radiotherapy with TomoTherapy-H, Linear Accelerator & Versa HD Radiotherapy Unit 1st in the region to start Bone Marrow Transplant & Hemato Oncology department with 4 procedure rooms. Started Robotic Surgery."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Curie Manavata Cancer Centre


During the past decade, Curie Manavata Cancer Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Curie Manavata Cancer Centre


According to Clinical.Site data, the most researched conditions in "Curie Manavata Cancer Centre" are "Breast Neoplasms" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Curie Manavata Cancer Centre" in a lesser frequency.

Clinical Trials Intervention Types at Curie Manavata Cancer Centre


Most popular intervention types in "Curie Manavata Cancer Centre" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Afatinib" (1 trials), "Afatinib 40mg once daily (OD)" (1 trials), "Paclitaxel 80 mg/m2 weekly" (1 trials) and "Vinorelbine 25 mg/m2 weekly" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Curie Manavata Cancer Centre


The vast majority of trials in "Curie Manavata Cancer Centre" are 1 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Curie Manavata Cancer Centre


Currently, there are NaN active trials in "Curie Manavata Cancer Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Curie Manavata Cancer Centre, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Curie Manavata Cancer Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".